CVS Health Corporation · NYSE:CVS
CVS Health — Q2 2021 Earnings Presentation
8 slides from CVS Health's earnings presentation, May 2021
Slide 1: Anticipated Launches | Q2 2021 – Q3 2021
Anticipated Launches | Q2 2021 – Q3 2021
Slide 2: Specialty Pharmacy Pipeline Drugs to Watch
Specialty Pharmacy Pipeline Drugs to Watch Anticipated Launches – 2nd Quarter 2021 to 3rd Quarter 2021 Product Name, Route of Select Available U.S. Food Administration and Drug Administration Therapeutic and Proposed Phase of Disease Prevalence and (FDA) Approved Category Manufacturer1 Indication1 S
Slide 3: Specialty Pharmacy Pipeline Drugs to Watch
Specialty Pharmacy Pipeline Drugs to Watch Anticipated Launches – 2nd Quarter 2021 to 3rd Quarter 2021 Product Name, Route of Select Available U.S. Food Administration and Drug Administration Therapeutic and Proposed Phase of Disease Prevalence and (FDA) Approved Category Manufacturer1 Indication1 S
Slide 4: Specialty Pharmacy Pipeline Drugs to Watch
Specialty Pharmacy Pipeline Drugs to Watch Anticipated Launches – 2nd Quarter 2021 to 3rd Quarter 2021 Product Name, Route of Select Available U.S. Food Administration and Drug Administration Therapeutic and Proposed Phase of Disease Prevalence and (FDA) Approved Category Manufacturer1 Indication1 S
Slide 5: Specialty Pharmacy Pipeline Drugs to Watch
Specialty Pharmacy Pipeline Drugs to Watch Anticipated Launches – 2nd Quarter 2021 to 3rd Quarter 2021 Product Name, Route of Select Available U.S. Food Administration and Drug Administration Therapeutic and Proposed Phase of Disease Prevalence and (FDA) Approved Category Manufacturer1 Indication1 S
Slide 6: Specialty Pharmacy Pipeline Drugs to Watch
Specialty Pharmacy Pipeline Drugs to Watch Anticipated Launches – 2nd Quarter 2021 to 3rd Quarter 2021 Product Name, Route of Select Available U.S. Food Administration and Drug Administration Therapeutic and Proposed Phase of Disease Prevalence and (FDA) Approved Category Manufacturer1 Indication1 S
Slide 7: Specialty Pharmacy Pipeline Drugs to Watch
Specialty Pharmacy Pipeline Drugs to Watch Anticipated Launches – 2nd Quarter 2021 to 3rd Quarter 2021 Product Name, Route of Select Available U.S. Food Administration and Drug Administration Therapeutic and Proposed Phase of Disease Prevalence and (FDA) Approved Category Manufacturer1 Indication1 S
Slide 8: References
Specialty Pharmacy Pipeline Drugs to Watch Anticipated Launches – 2nd Quarter 2021 to 3rd Quarter 2021 13 American Cancer Society – Key Statistics for Lung Cancer. Available at https://www.cancer.org/cancer/lung-cancer/about/key-statistics.html. Accessed March 15, 2021. 14 Hong DS, Fakih MW, Strickl